Interim report Q1/2022: Our financial targets remain in place

Significant Significant events after the quarterevents inQ1 · In · In April, Enzymatica announced that its mouth spray would beMarch, launched in Turkey by its partner Sanofi in 2022. The productEnzymatica will be sold under one of Sanofi’s own brands.announcedthat itsmouth spraywould belaunched inMexico byits partnerSanofi in2022. Theproductwill besold underone ofSanofi’sown brands.   Other events  during thequarter · In January,Enzymatica’spartner STADAtook overresponsibilityin Denmark,Norway and